These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 28359621)

  • 21. Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.
    Choi UY; Huh DH; Kim JH; Kang JH
    Hum Vaccin Immunother; 2016 Oct; 12(10):2560-2564. PubMed ID: 27484734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroepidemiology of varicella and the reliability of a self-reported history of varicella infection in Singapore military recruits.
    Dashraath P; Ong ES; Lee VJ
    Ann Acad Med Singap; 2007 Aug; 36(8):636-41. PubMed ID: 17767333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varicella-zoster virus immunity among health care workers in Catalonia.
    Urbiztondo L; Bayas JM; Broner S; Costa J; Esteve M; Campins M; Borrás E; Domínguez A;
    Vaccine; 2014 Oct; 32(45):5945-8. PubMed ID: 25219564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
    Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
    Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term immunogenicity and safety of hepatitis-A and varicella vaccines in HIV-exposed uninfected and HIV-unexposed South African children.
    Mutsaerts EAML; Nunes MC; Bhikha S; Ikulinda BT; Jose L; Koen A; Moultrie A; Grobbee DE; Klipstein-Grobusch K; Weinberg A; Madhi SA
    Vaccine; 2020 May; 38(22):3862-3868. PubMed ID: 32307279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunology of Varicella Immunization in the elderly.
    Raeder CK; Hayney MS
    Ann Pharmacother; 2000 Feb; 34(2):228-34. PubMed ID: 10676831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella zoster virus immunity in multinational health care workers of a Saudi Arabian hospital.
    Almuneef M; Dillon J; Abbas MF; Memish Z
    Am J Infect Control; 2003 Oct; 31(6):375-81. PubMed ID: 14608306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
    Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
    Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients.
    Chaves Tdo S; Lopes MH; de Souza VA; Dos Santos Sde S; Pereira LM; Reis AD; David-Neto E
    Pediatr Transplant; 2005 Apr; 9(2):192-6. PubMed ID: 15787792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of Immune Response and Protective Immunity by a Local Isolated Varicella Virus in Animal Model: A Future Candidates for Vaccine Production.
    Esna-Ashari F; Sabahi F; Ravanshad M; Mohammadi A
    Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):586-593. PubMed ID: 30644703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines.
    Kopylov U; Levin A; Mendelson E; Dovrat S; Book M; Eliakim R; Ben-Horin S
    Aliment Pharmacol Ther; 2012 Jul; 36(2):145-50. PubMed ID: 22612376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization.
    Haumont M; Jurdan M; Kangro H; Jacquet A; Massaer M; Deleersnyder V; Garcia L; Bosseloir A; Bruck C; Bollen A; Jacobs P
    J Med Virol; 1997 Sep; 53(1):63-8. PubMed ID: 9298734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.
    Weinberg A; Lazar AA; Zerbe GO; Hayward AR; Chan IS; Vessey R; Silber JL; MacGregor RR; Chan K; Gershon AA; Levin MJ
    J Infect Dis; 2010 Apr; 201(7):1024-30. PubMed ID: 20170376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
    Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
    J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
    Kho MM; Zuijderwijk JM; van der Eijk AA; de Kuiper R; Boer-Verschragen MJ; Weimar W; van Besouw NM
    Vaccine; 2017 Jan; 35(1):71-76. PubMed ID: 27899225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroepidemiology of varicella-zoster virus antibodies among health-care workers and day-care-centre workers.
    Lerman Y; Chodick G; Tepper S; Livni G; Ashkenazi S
    Epidemiol Infect; 2004 Dec; 132(6):1135-8. PubMed ID: 15635972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial.
    Dubey AP; Faridi MMA; Mitra M; Kaur IR; Dabas A; Choudhury J; Mukherjee M; Mishra D
    Hum Vaccin Immunother; 2017 Sep; 13(9):2032-2037. PubMed ID: 28509605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.
    Saiman L; LaRussa P; Steinberg SP; Zhou J; Baron K; Whittier S; Della-Latta P; Gershon AA
    Infect Control Hosp Epidemiol; 2001 May; 22(5):279-83. PubMed ID: 11428437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.